Cargando…
Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1987
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001718/ https://www.ncbi.nlm.nih.gov/pubmed/3606945 |
| _version_ | 1782135661611974656 |
|---|---|
| author | Eisenhauer, E. A. Silver, H. K. Venner, P. M. Thirlwell, M. P. Weinerman, B. Coppin, C. M. |
| author_facet | Eisenhauer, E. A. Silver, H. K. Venner, P. M. Thirlwell, M. P. Weinerman, B. Coppin, C. M. |
| author_sort | Eisenhauer, E. A. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2001718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1987 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-20017182009-09-10 Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. Eisenhauer, E. A. Silver, H. K. Venner, P. M. Thirlwell, M. P. Weinerman, B. Coppin, C. M. Br J Cancer Research Article Nature Publishing Group 1987-05 /pmc/articles/PMC2001718/ /pubmed/3606945 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Eisenhauer, E. A. Silver, H. K. Venner, P. M. Thirlwell, M. P. Weinerman, B. Coppin, C. M. Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. |
| title | Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. |
| title_full | Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. |
| title_fullStr | Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. |
| title_full_unstemmed | Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. |
| title_short | Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group. |
| title_sort | phase ii study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. a study of the national cancer institute of canada clinical trials group. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001718/ https://www.ncbi.nlm.nih.gov/pubmed/3606945 |
| work_keys_str_mv | AT eisenhauerea phaseiistudyofhighdoseweeklyintravenoushumanlymphoblastoidinterferoninrenalcellcarcinomaastudyofthenationalcancerinstituteofcanadaclinicaltrialsgroup AT silverhk phaseiistudyofhighdoseweeklyintravenoushumanlymphoblastoidinterferoninrenalcellcarcinomaastudyofthenationalcancerinstituteofcanadaclinicaltrialsgroup AT vennerpm phaseiistudyofhighdoseweeklyintravenoushumanlymphoblastoidinterferoninrenalcellcarcinomaastudyofthenationalcancerinstituteofcanadaclinicaltrialsgroup AT thirlwellmp phaseiistudyofhighdoseweeklyintravenoushumanlymphoblastoidinterferoninrenalcellcarcinomaastudyofthenationalcancerinstituteofcanadaclinicaltrialsgroup AT weinermanb phaseiistudyofhighdoseweeklyintravenoushumanlymphoblastoidinterferoninrenalcellcarcinomaastudyofthenationalcancerinstituteofcanadaclinicaltrialsgroup AT coppincm phaseiistudyofhighdoseweeklyintravenoushumanlymphoblastoidinterferoninrenalcellcarcinomaastudyofthenationalcancerinstituteofcanadaclinicaltrialsgroup |